多药
耐受性
精神分裂症谱
荟萃分析
抗精神病药
精神分裂症(面向对象编程)
医学
精神科
心理学
精神病
内科学
不利影响
作者
M.W.H. Lochmann van Bennekom,Joanna IntHout,Harm J. Gijsman,Berna Binnur Akdede,A. Elif Anıl Yağcıoğlu,Thomas R. E. Barnes,Britta Galling,Ralitza Gueorguieva,Per Bech,Anatoly Kreinin,Jimmi Nielsen,René Ernst Nielsen,Gary Remington,Eila Repo‐Tiihonen,Christian Schmidt-Kraepelin,Saeed Shoja Shafti,Le Xiao,Christoph U. Correll,Robbert‐Jan Verkes
标识
DOI:10.1016/j.schres.2024.07.035
摘要
Antipsychotic polypharmacy (APP) is frequently prescribed for schizophrenia-spectrum disorders. Despite the inconsistent findings on efficacy, APP may be beneficial for subgroups of psychotic patients. This meta-analysis of individual patient data investigated moderators of efficacy and tolerability of APP in adult patients with schizophrenia-spectrum disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI